Pacagen Biotech Visit site

3 known investors

Pacagen develops allergen-neutralizing sprays using proprietary WhiskerBlock™ and EnviroBlock™ technologies that target pet and dust mite allergens at the molecular level. The company serves allergy sufferers seeking an alternative to traditional antihistamines and medications.